舒利迭合并思力华治疗COPD肺心病患者的临床观察
目的:探讨舒利迭联合思力华治疗慢性阻塞性肺心病患者的临床效果。方法:选择2012-2013年入我院进行治疗的56例中重度稳定器慢性阻塞性肺心病患者,随机分为试验组和对照组,每组患者28例,试验组采用舒利迭联合思力华治疗,对照组仅采用舒利迭治疗,治疗时间为3个月。在治疗前后观察记录两组患者临床症状、肺功能指数、血气分析结果并进行比较。结果:在足疗程治疗后,试验组和对照组的患者临床症状均得到改善,试验组临床症状缓解率明显优于对照组患者;治疗后试验组和对照组患者的动脉血气分析结果均得到改善,两组患者在整个治疗期间无明显不良反应。结论:采用舒利迭合并思力华治疗慢性阻塞性肺心病取得了较好的临床效果,且不良反应少,起效快,值得在临床中应用。
标签:肺心病;舒利迭;思力华
[Abstract]Objective:To investigate the joint Seretide Spiriva clinical effects of chronic obstructive pulmonary heart disease patients.Methods:2012-2013 into the hospital for treatment of moderate to severe stabilizer patients with chronic obstructive pulmonary heart disease,56 cases were randomly divided into experimental group and control group,28 patients in each group,the experimental group using Seretide Spiriva joint treatment,the control group,only the use of Seretide treatment for 3 months.Before and after treatment groups were observed and recorded clinical symptoms,lung function indices,blood gas analysis and the results were compared.After the full course of treatment results in the test group and the control group of patients with clinical symptoms were improved,the test group of clinical symptoms was significantly better than the control group of patients;experimental group and a control group of patients with arterial blood gas analysis results were improved after treatment,two groups of patients throughout the treatment period no significant adverse reactions.Conclusion:Seretide Spiriva combined treatment of chronic obstructive pulmonary heart disease achieved better clinical results and fewer side effects,rapid onset,worthy of clinical application.
[Key words]Cor;Seretide;Spiriva
慢性阻塞性肺部疾病(COPD)以呼吸气流受限为主要临床特征的慢性呼吸系统疾病[1],病理特征为慢性炎症、气流受限、病理呈现进行性发展,主要临床表现为咳嗽、咳痰、呼吸困难等,其发病率和致死率均较高,患病后严重影响患者的劳动力及生活能力,临床中治疗慢性阻塞性肺病的方法以药物治疗为主。讨论
舒利迭是一种美沙特罗和丙酸氟替卡松的复方制剂[3]。思力华为噻托溴铵是一种长效季铵类抗胆碱能支气管扩张剂,拮抗起到内的M受体,从而抑制胆碱能神经释放乙酰胆碱[4-5]。联合应用思力华和舒利迭有利于改善COPD稳定期患者的肺功能。
参考文献
[1]吴洁,赵军,吴群.思力华联合舒利迭对稳定期COPD患者肺功能的疗效观察[J].首都医药,2013,(14):67-68.
[2]华鹏炯.两种药物对中重度COPD患者疗效机制影响的研究[J].中国现代医生,2012,50(5):45-47.
[3]游建明,陈乐鸿,陈泽芳.舒利迭联合思力华治疗稳定期慢性阻塞性肺疾病的临床观察[J].大家健康,2012,6(8):23-24.
[4]马利娟,杨秀枝.吸入舒利迭和思力华治疗稳定期COPD疗效观察[J].中国现代医生,2011,49(10):26-27.
[5]张越,宋威蓉,陈丽萍.舒利迭联合思力华治疗稳定期慢性阻塞性肺疾病的临床疗效观察[J].中国民族民间医药,2012,2(13):121-122.
因篇幅问题不能全部显示,请点此查看更多更全内容